Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03365011 · ClinicalTrials.gov registry record · Phase 4
Nitrous Oxide Treatment for Tinnitus
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT03365011 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT03365011, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Tinnitus is perception of sound without the presence of an external acoustic stimulus. Approximately 50 million Americans experience chronic tinnitus and of these, 10 million have bothersome tinnitus. The tinnitus research literature suggests that NMDA receptor antagonists may prove to be useful in reducing tinnitus. Nitrous oxide, a member of the NMDA receptor antagonist class, is a widely-used general anesthetic and sedative with a proven safety profile. The investigators hypothesized that the administration of nitrous oxide, an NMDA receptor antagonist, may be effective in treatment of tinnitus. The study design was a randomized placebo-controlled crossover trial.
Interventions
- DRUG Nitrous oxide gas for inhalation
- DRUG Placebo gas for inhalation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03365011
The ClinicalTrials.gov registry entry for NCT03365011 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitrous oxide gas for inhalation is the first listed.
NCT03365011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03365011 about?
NCT03365011 is a clinical study titled "Nitrous Oxide Treatment for Tinnitus". Tinnitus is perception of sound without the presence of an external acoustic stimulus. Approximately 50 million Americans experience chronic tinnitus and of these, 10 million have bothersome tinnitus. The tinnitus research literature suggests that NMDA receptor antagonists may prove to be useful in ...
What is the current status of trial NCT03365011?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2016-10. Estimated completion is 2017-07.
What interventions are being tested in trial NCT03365011?
The interventions under investigation include: Nitrous oxide gas for inhalation (DRUG), Placebo gas for inhalation (DRUG).
Who is sponsoring clinical trial NCT03365011?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.